Key statistics
On Monday, ADMA Biologics Inc (ADMA:NMQ) closed at 16.58, 22.81% above the 52 week low of 13.50 set on Mar 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 15.70 |
|---|---|
| High | 17.16 |
| Low | 15.70 |
| Bid | 15.90 |
| Offer | 17.00 |
| Previous close | 15.57 |
| Average volume | 4.03m |
|---|---|
| Shares outstanding | 238.16m |
| Free float | 227.56m |
| P/E (TTM) | 25.97 |
| Market cap | 3.71bn USD |
| EPS (TTM) | 0.5996 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
- ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
- ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
- ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
- ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
- ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
- ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
- ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
- ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
More ▼
